Late-Life Menopause Linked to Higher Asthma Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 30, 2024.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Oct. 30, 2024 -- Women who enter menopause at a later age have a greater risk of asthma, a new study says.

Meanwhile, early menopause is associated with a reduced risk of developing asthma, researchers found.

The results run counter to other studies suggesting that early menopause, defined as ages 40 to 44, is more detrimental to a woman’s health, increasing her risk of heart disease, diabetes, osteoporosis and depression, the researchers noted.

They also provide additional evidence for a link between female hormones and asthma, the team led by Durmalouk Kesibi, from York University in Toronto, found.

Childhood asthma is more prevalent in boys than girls, but adult-onset asthma is more common in women than men. Women also tend to have more severe asthma, and they are less likely to have their asthma go into remission, researchers noted.

"This study highlights sex-based differences in asthma, with women at a greater risk for asthma than men in adulthood,” said Dr. Stephanie Faubion, medical director for The Menopause Society.

“It also showed that women with later onset of menopause are at greater risk than those with early onset of menopause,” Faubion added in a society news release. “Clinicians should be aware of this link and should monitor women with later age at natural menopause for asthma symptoms.”

For this study, researchers reviewed data on more than 14,000 postmenopausal women with 10 years of follow-up.

Both natural estrogen and synthetic estrogen increase risk of asthma, researchers noted.

Women using hormone therapy have a 63% increased risk of asthma, while women who stop hormone therapy are twice as likely to quit asthma treatment, researchers said.

Higher BMI is also an asthma risk factor for women, because fat produces estrogen, researchers said.

The new study was published Oct. 30 in the journal Menopause.

Sources

  • The Menopause Society, news release, Oct. 30, 2024
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords